This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cyanotech Reports Financial Results For The First Quarter Of Fiscal 2012

“The significant increases in packaged product sales are attributed to our focus on the growing consumer market for health and nutrition supplement products, combined with recent media reports regarding the benefits of both astaxanthin and spirulina.”

“We believe that Cyanotech’s high-quality, Hawaiian spirulina and natural astaxanthin will continue to benefit from increasing general consumer demand for natural nutritional products with proven value,” Bailey concluded.

Cash and cash equivalents at June 30, 2011 compared to March 31, 2011 were $3,109,000 compared to $2,062,000. Working capital was $6,715,000 compared to $6,285,000. Inventory was $2,809,000 compared to $3,627,000.

For the first quarter of fiscal 2011, Spirulina sales accounted for 37% of total revenues and natural Astaxanthin sales for 63%. International sales were 40% of total sales.

About CyanotechCyanotech Corporation, a world leader in microalgae technology, produces BioAstin® Natural Astaxanthin and Hawaiian Spirulina Pacifica®—all natural, functional nutrients that leverage our experience and reputation for quality, building nutritional brands which promote health and well being. Cyanotech's Spirulina products offer complete nutrition, and augment energy and immune response. They are FDA reviewed and accepted as Generally Recognized as Safe (GRAS) for use in food products. BioAstin's superior antioxidant activity and ability to support and maintain a natural anti-inflammatory response enhance skin, muscle and joint health. All Cyanotech products are produced from microalgae grown at its 90-acre facility in Kona, Hawaii using patented and proprietary technology. Cyanotech distributes to nutritional supplement, nutraceutical and cosmeceutical manufacturers and marketers in more than 54 countries worldwide. Cyanotech was the first microalgae company in the world to obtain quality management standards ISO 9001:2000 certification and is GMP-certified by the Natural Products Association TM . Visit www.cyanotech.com for more information.

“Safe Harbor” Statement under the U.S. Private Securities Litigation Reform Act of 1995 Besides statements of present fact and historical fact, this press release may contain forward-looking statements. Forward-looking statements relate to the future and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by forward-looking statements. We caution against relying on forward-looking statements. Important factors that could change actual, future results include: changes in sales levels to our largest customers, weather patterns in Hawaii, production problems, risks associated with new products, foreign exchange fluctuations, and availability of financing, as well as national and global political, economic, business, competitive, market and regulatory conditions. Other factors are more fully detailed in the Company’s recent Form 10-Q and annual Form 10-K filings with the Securities and Exchange Commission.

( Financial Tables Follow: The following tables do not contain footnotes or other information contained in the Company’s Form 10-Q for the period ended June 30, 2011. As such the following Financial Tables are provided only as a guide and other factors are more fully detailed in the Company’s Form 10-Q and annual Form 10-K filings with the Securities and Exchange Commission.)
 
CYANOTECH CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
 

(Dollars in thousands except par value and number of shares)

(Unaudited)
 
June 30, 2011 March 31, 2011
ASSETS
Current assets:
Cash and cash equivalents $ 3,109 $ 2,062
Accounts receivable, net of allowance for doubtful accounts of $58 at June 30, 2011 and March 31, 2011 2,762 2,641
Inventories, net 2,809 3,627
Deferred tax assets 17 17
Prepaid expenses and other assets 147 134
Total current assets 8,844 8,481
 
Equipment and leasehold improvements, net 4,649 4,557
Deferred tax assets 535 535
Other assets 279 287
Total assets $ 14,307 $ 13,860
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current maturities of long-term debt $ 217 $ 204
Customer deposits 97 115
Accounts payable 981 1,054
Accrued expenses 834 823
Total current liabilities 2,129 2,196
 
Long-term debt, excluding current maturities 531 553
Total liabilities 2,660 2,749
 
Commitments and contingencies
 
Stockholders’ equity:
Common stock of $0.02 par value, shares authorized 7,500,000; 5,395,168 shares issued and outstanding at June 30, 2011 and 5,395,168 at March 31, 2011 108 108
Additional paid-in capital 27,853 27,803
Accumulated deficit (16,314 ) (16,800 )
Total stockholders’ equity 11,647 11,111
 
Total liabilities and stockholders’ equity $ 14,307 $ 13,860
 
 
CYANOTECH CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
 

(Dollars in thousands, except per share amounts)

(Unaudited)
 
Three Months Ended June 30,
2011 2010
 
NET SALES $ 5,950 $ 3,856
COST OF SALES 3,846 2,197
Gross Profit 2,104 1,659
 
OPERATING EXPENSES:
General and administrative 948 763
Sales and marketing 567 383
Research and development 71 84
Loss on disposal of equipment and leasehold improvements 2
Total operating expenses 1,588 1,230
 
Income from operations 516 429
 
Interest expense, net (14 ) (20 )
 
Income before income taxes 502 409
 
PROVISION FOR INCOME TAXES 16 10
 
NET INCOME $ 486 $ 399
 
NET INCOME PER SHARE:
Basic $ 0.09 $ 0.08
Diluted $ 0.09 $ 0.07
 
SHARES USED IN CALCULATION OF NET INCOME PER SHARE:
Basic 5,395 5,253
Diluted 5,460 5,321

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs